Ultrasound findings are not useful for defining stage Tic prostate cancer
- 1 November 1997
- journal article
- review article
- Published by Springer Nature in World Journal of Urology
- Vol. 15 (6), 336-338
- https://doi.org/10.1007/bf01300180
Abstract
The management of stage T1c prostate cancer is identical to that of stage T2 prostate cancer. The treatment of a cancer detected by an elevated PSA level depends primarily on the age and health of the patient, on his preferences for treatment, and on the manner in which the physician presents the options. The distinction between PSA-detected tumors that are visible on ultra sound and PSA-detected tumors that are invisible on ultrasound is not clinically useful.Keywords
This publication has 21 references indexed in Scilit:
- Evaluation of a Nomogram used to predict the pathologic stage of clinically localized prostate carcinomaCancer, 1997
- Core cancer length in ultrasound-guided systematic sextant biopsies: a preoperative evaluation of prostate cancer volumeUrology, 1995
- The Significance of Isoechoic Prostatic CarcinomaJournal of Urology, 1994
- Re: The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer, by A. W. Partin, J. Yoo, H. B. Carter, J. D. Pearson, D. W. Chan, J. I. Epstein and P. C. Walsh, J. Urol., 150: 110–115, 1993Journal of Urology, 1994
- PSA-detected (clinical stage T1c or B0) prostate cancer. Pathologically significant tumors.1993
- Clinical stage Bo or T1c prostate cancer: Nonpalpable disease identified by elevated serum prostate-specific antigen concentrationUrology, 1993
- Transrectal ultrasound for staging prior to radical prostatectomyUrology, 1989
- Preoperative Evaluation of Localized Prostatic Carcinoma by Transrectal UltrasonographyJournal of Urology, 1985
- Transrectal Ultrasonography for Prostatic Cancer: Its Value in Staging and Monitoring the Response to Radiotherapy and ChemotherapyJournal of Urology, 1985
- Diagnostic accuracy and its limitations in prostatic cancer by means of transrectal ultrasonotomography.1983